AQP2

aquaporin 2, the group of Aquaporins

Basic information

Region (hg38): 12:49950737-49958878

Links

ENSG00000167580NCBI:359OMIM:107777HGNC:634Uniprot:P41181AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • nephrogenic diabetes insipidus (Supportive), mode of inheritance: AD
  • diabetes insipidus, nephrogenic, autosomal (Strong), mode of inheritance: AR
  • diabetes insipidus, nephrogenic, autosomal (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Diabetes insipidus, nephrogenic, 2AD/AREndocrine; RenalIndividuals can present in infancy with hypernatremia and severe dehydration, and recognition may allow preventive measures and prompt treatmentEndocrine; Renal1828422; 8140421; 7524315; 9649557; 16845277

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the AQP2 gene.

  • not_provided (258 variants)
  • Diabetes_insipidus,_nephrogenic,_autosomal (104 variants)
  • Nephrogenic_diabetes_insipidus (50 variants)
  • Inborn_genetic_diseases (23 variants)
  • not_specified (13 variants)
  • AQP2-related_disorder (2 variants)
  • Hereditary_disease (1 variants)
  • Diabetes_insipidus (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the AQP2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000486.6. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
145
clinvar
2
clinvar
150
missense
6
clinvar
23
clinvar
87
clinvar
8
clinvar
124
nonsense
8
clinvar
6
clinvar
14
start loss
1
1
frameshift
11
clinvar
8
clinvar
19
splice donor/acceptor (+/-2bp)
1
clinvar
7
clinvar
8
Total 27 44 90 153 2

Highest pathogenic variant AF is 0.0000960566

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
AQP2protein_codingprotein_codingENST00000199280 48141
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000002490.3091257100381257480.000151
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.061371770.7760.00001161694
Missense in Polyphen5473.8160.73154693
Synonymous-0.4239085.01.060.00000602631
Loss of Function0.25799.870.9125.54e-785

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005630.000559
Ashkenazi Jewish0.000.00
East Asian0.0001090.000109
Finnish0.00004650.0000462
European (Non-Finnish)0.0001210.000114
Middle Eastern0.0001090.000109
South Asian0.0001740.000163
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Forms a water-specific channel that provides the plasma membranes of renal collecting duct with high permeability to water, thereby permitting water to move in the direction of an osmotic gradient.;
Disease
DISEASE: Diabetes insipidus, nephrogenic, autosomal (ANDI) [MIM:125800]: A disorder caused by the inability of the renal collecting ducts to absorb water in response to arginine vasopressin. Characterized by excessive water drinking (polydipsia), excessive urine excretion (polyuria), persistent hypotonic urine, and hypokalemia. Inheritance can be autosomal dominant or recessive. {ECO:0000269|PubMed:12050236, ECO:0000269|PubMed:12191971, ECO:0000269|PubMed:15509592, ECO:0000269|PubMed:16120822, ECO:0000269|PubMed:16361827, ECO:0000269|PubMed:16845277, ECO:0000269|PubMed:19585583, ECO:0000269|PubMed:19701945, ECO:0000269|PubMed:24944815, ECO:0000269|PubMed:7524315, ECO:0000269|PubMed:8882880, ECO:0000269|PubMed:9048343, ECO:0000269|PubMed:9302264, ECO:0000269|PubMed:9402087, ECO:0000269|PubMed:9550615, ECO:0000269|PubMed:9649557, ECO:0000269|PubMed:9745427}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Vasopressin-regulated water reabsorption - Homo sapiens (human);Polythiazide Action Pathway;Methyclothiazide Action Pathway;Bumetanide Action Pathway;Spironolactone Action Pathway;Eplerenone Action Pathway;Triamterene Action Pathway;Amiloride Action Pathway;Ethacrynic Acid Action Pathway;Quinethazone Action Pathway;Bendroflumethiazide Action Pathway;Chlorthalidone Action Pathway;Trichlormethiazide Action Pathway;Iminoglycinuria;Lysinuric Protein Intolerance;Blue diaper syndrome;Lysinuric protein intolerance (LPI);Cystinuria;Indapamide Action Pathway;Furosemide Action Pathway;Torsemide Action Pathway;Hartnup Disorder;Glucose Transporter Defect (SGLT2);Kidney Function;Glucose Transporter Defect (SGLT2);Metolazone Action Pathway;Hydrochlorothiazide Action Pathway;Cyclothiazide Action Pathway;Hydroflumethiazide Action Pathway;Chlorothiazide Action Pathway;Transport of small molecules;Passive transport by Aquaporins;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport (Consensus)

Recessive Scores

pRec
0.606

Intolerance Scores

loftool
0.199
rvis_EVS
-0.52
rvis_percentile_EVS
21.2

Haploinsufficiency Scores

pHI
0.227
hipred
Y
hipred_score
0.665
ghis
0.487

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.741

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Aqp2
Phenotype
homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype;

Gene ontology

Biological process
renal water homeostasis;renal water transport;water transport;excretion;glycerol transport;cellular response to water deprivation;transmembrane transport;cellular response to copper ion;cellular response to mercury ion;metanephric collecting duct development
Cellular component
Golgi apparatus;plasma membrane;membrane;integral component of membrane;basolateral plasma membrane;apical plasma membrane;transport vesicle membrane;recycling endosome;extracellular exosome
Molecular function
water transmembrane transporter activity;protein binding;glycerol transmembrane transporter activity;water channel activity